These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3841210)

  • 1. Differential salicylate-aspirin interaction on vascular prostacyclin and platelet thromboxane synthesis in patients undergoing saphenectomy.
    Dejana E; Costantini V; De Amicis G; Cerletti C; Lorenzi G; de Gaetano G
    Proc Soc Exp Biol Med; 1985 Dec; 180(3):533-7. PubMed ID: 3841210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits.
    Buchanan MR; Hirsh J
    Arteriosclerosis; 1984; 4(4):403-6. PubMed ID: 6380468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction.
    de Gaetano G; Cerletti C; Dejana E; Latini R
    Circulation; 1985 Dec; 72(6):1185-93. PubMed ID: 2998640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man.
    Rosenkranz B; Fischer C; Meese CO; Frölich JC
    Br J Clin Pharmacol; 1986 Mar; 21(3):309-17. PubMed ID: 3083851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function.
    Cerletti C; Bonati M; del Maschio A; Galletti F; Dejana E; Tognoni G; de Gaetano G
    J Lab Clin Med; 1984 Jun; 103(6):869-77. PubMed ID: 6726057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of enteric-coated aspirin and inhibition of platelet thromboxane A2 and vascular prostacyclin generation in humans.
    Cerletti C; Marchi S; Lauri D; Domanin M; Lorenzi G; Urso R; Dejana E; Latini R; de Gaetano G
    Clin Pharmacol Ther; 1987 Aug; 42(2):175-80. PubMed ID: 3301151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis.
    Hanley SP; Bevan J; Cockbill SR; Heptinstall S
    Lancet; 1981 May; 1(8227):969-71. PubMed ID: 6112387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triflusal vs aspirin on the inhibition of human platelet and vascular cyclooxygenase.
    de la Cruz JP; Mata JM; Sanchez de la Cuesta F
    Gen Pharmacol; 1992 Mar; 23(2):297-300. PubMed ID: 1639242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis.
    Keimowitz RM; Pulvermacher G; Mayo G; Fitzgerald DJ
    Circulation; 1993 Aug; 88(2):556-61. PubMed ID: 8339418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet adhesivity to subendothelium is influenced by polymorphonuclear leukocytes: studies with aspirin and salicylate.
    Hernández R; Alemany M; Bozzo J; Buchanan MR; Ordinas A; Bastida E
    Haemostasis; 1993; 23(1):1-7. PubMed ID: 8477903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs.
    Reilly IA; FitzGerald GA
    Blood; 1987 Jan; 69(1):180-6. PubMed ID: 3790723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
    Clarke RJ; Mayo G; Price P; FitzGerald GA
    N Engl J Med; 1991 Oct; 325(16):1137-41. PubMed ID: 1891022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension.
    Benigni A; Gregorini G; Frusca T; Chiabrando C; Ballerini S; Valcamonico A; Orisio S; Piccinelli A; Pinciroli V; Fanelli R
    N Engl J Med; 1989 Aug; 321(6):357-62. PubMed ID: 2664523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo.
    Kyrle PA; Eichler HG; Jäger U; Lechner K
    Circulation; 1987 May; 75(5):1025-9. PubMed ID: 3552295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo formation of prostacyclin and thromboxane A2 at the site of platelet-vascular interaction in humans.
    Nowak J; FitzGerald GA
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():208-11. PubMed ID: 2959050
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.
    Mehta JL; Mehta P; Lopez L; Ostrowski N; Aguila E
    J Am Coll Cardiol; 1984 Oct; 4(4):806-11. PubMed ID: 6384329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo measurement of thromboxane B2 and 6-keto-prostaglandin F1 alpha in humans in response to a standardized vascular injury and the influence of aspirin.
    Gerrard JM; Taback S; Singhroy S; Docherty JC; Kostolansky I; McNicol A; Kobrinsky NL; McKenzie JK; Rowe R
    Circulation; 1989 Jan; 79(1):29-38. PubMed ID: 2910545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats.
    Gambino MC; Passaghe S; Chen ZM; Bucchi F; Gori G; Latini R; de Gaetano G; Cerletti C
    J Pharmacol Exp Ther; 1988 Apr; 245(1):287-90. PubMed ID: 3129553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition.
    Dejana E; Cerletti C; de Castellarnau C; Livio M; Galletti F; Latini R; de Gaetano G
    J Clin Invest; 1981 Oct; 68(4):1108-12. PubMed ID: 6793630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.